Skip to content

Study · Measured the body's own peptide · 1982

1 result

Effects of 6-hydroxydopamine upon primary and secondary thymus dependent immune responses.

Hall NR, McClure JE, Hu SK, Tare NS, Seals CM, Goldstein AL

Immunopharmacology1 Oct 1982Cited by 49 (Europe PMC)

PMID6813289 (opens in a new tab)DOI10.1016/0162-3109(82)90035-2 (opens in a new tab)PepBankPUB-06813289
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In adult male mice, serum levels of the body's own thymosin alpha‑1 rose by day three after 6-hydroxydopamine and returned to normal by day five.

    In plain wordsIn mice, 6-hydroxydopamine raised the body's own thymosin alpha‑1 level in blood by day three, and it returned to normal by day five.

    Peptide
    Thymosin alpha-1
    Outcome
    IncreaseSerum thymosin alpha 1 level after 6-OHDA
    Study

    mousen: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Serum levels of thymosin alpha 1 were increased by day three after 6-OHDA with a return to normal by day five.
    1 context sentence
    Summary · context
    Adult male mice were treated with various doses of 6-hydroxydopamine in order to assess the effects of this drug upon thymic dependent immunity.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.